Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Automatic Detection and Classification of Epileptic Seizures from EEG Data: Finding Optimal Acquisition Settings and Testing Interpretable Machine Learning Approach.
Statsenko Y, Babushkin V, Talako T, Kurbatova T, Smetanina D, Simiyu GL, Habuza T, Ismail F, Almansoori TM, Gorkom KN, Szólics M, Hassan A, Ljubisavljevic M. Statsenko Y, et al. Among authors: szolics m. Biomedicines. 2023 Aug 24;11(9):2370. doi: 10.3390/biomedicines11092370. Biomedicines. 2023. PMID: 37760815 Free PMC article.
Unraveling Lifelong Brain Morphometric Dynamics: A Protocol for Systematic Review and Meta-Analysis in Healthy Neurodevelopment and Ageing.
Statsenko Y, Habuza T, Smetanina D, Simiyu GL, Meribout S, King FC, Gelovani JG, Das KM, Gorkom KN, Zaręba K, Almansoori TM, Szólics M, Ismail F, Ljubisavljevic M. Statsenko Y, et al. Among authors: szolics m. Biomedicines. 2023 Jul 14;11(7):1999. doi: 10.3390/biomedicines11071999. Biomedicines. 2023. PMID: 37509638 Free PMC article.
Multimodal diagnostics in multiple sclerosis: predicting disability and conversion from relapsing-remitting to secondary progressive disease course - protocol for systematic review and meta-analysis.
Statsenko Y, Smetanina D, Arora T, Östlundh L, Habuza T, Simiyu GL, Meribout S, Talako T, King FC, Makhnevych I, Gelovani JG, Das KM, Gorkom KN, Almansoori TM, Al Zahmi F, Szólics M, Ismail F, Ljubisavljevic M. Statsenko Y, et al. Among authors: szolics m. BMJ Open. 2023 Jul 14;13(7):e068608. doi: 10.1136/bmjopen-2022-068608. BMJ Open. 2023. PMID: 37451729 Free PMC article.
Neuroimaging findings in a case of fluoxetine overdose.
Szólics M, Chaudhry M, Ljubisavljevic M, Corr P, Samir HA, van Gorkom KN. Szólics M, et al. J Neuroradiol. 2012 Oct;39(4):254-7. doi: 10.1016/j.neurad.2011.10.006. Epub 2011 Dec 22. J Neuroradiol. 2012. PMID: 22197403
The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective.
Alroughani R, Van Wijmeersch B, Al Khaboori J, Alsharoqi IA, Ahmed SF, Hassan A, Inshasi J, Krieger DW, Shakra M, Shatila AO, Szolics M, Khallaf M, Ezzat A. Alroughani R, et al. Among authors: szolics m. Ther Adv Neurol Disord. 2020 Sep 16;13:1756286420954119. doi: 10.1177/1756286420954119. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 32973927 Free PMC article. Review.
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study.
Inshasi J, Farouk S, Shatila A, Hassan A, Szolics M, Thakre M, Kayed D, Krieger D, Almadani A, Alsaadi T, Benedetti B, Mifsud V, Jacob A, Sayegh S, Boshra A, Alroughani R. Inshasi J, et al. Among authors: szolics m. Neurol Ther. 2023 Aug;12(4):1309-1318. doi: 10.1007/s40120-023-00497-2. Epub 2023 Jun 8. Neurol Ther. 2023. PMID: 37289421 Free PMC article.
25 results